Similar companies
Oramed Pharmaceuticals Monthly Web Traffic
Oramed Pharmaceuticals’s website receives an estimated 2,000 monthly visits, roughly flat (+0.0%) over the past three months.
At 2,000 monthly visits, Oramed Pharmaceuticals trails industry peers like Amgen (665,000) and Gilead Sciences (511,000).
How Web Traffic Impacts ORMP’s AI Score
Web traffic is a real-time read on consumer demand and brand engagement: for consumer-facing companies, a sustained change in website visits can precede changes in reported revenue. AltIndex feeds Oramed Pharmaceuticals’s monthly visit estimates into the ORMP AI Score as one of 25+ alternative data signals, where traffic momentum is weighed against hiring, sentiment, and fundamentals.
For other growth metrics, see Oramed Pharmaceuticals app downloads, Google Trends, Instagram followers, and LinkedIn headcount.
Month over Month
| Sep 2026 | 2,000 | |
| Aug 2026 | 3,000 | |
| Jul 2026 | 3,000 | |
| Jun 2026 | 2,000 | |
| May 2026 | 2,000 | |
| Apr 2026 | 3,000 |
Oramed Pharmaceuticals Web Traffic: Frequently Asked Questions
Oramed Pharmaceuticals's website receives approximately 2,000 monthly visits, based on AltIndex's estimate aggregated from the top web traffic data providers. This figure includes desktop and mobile visitors to the company's primary domain.
Oramed Pharmaceuticals's web traffic has been roughly flat (+0.0%) over the past three months.
Web traffic is a real-time indicator of consumer demand and brand engagement. For consumer-facing companies, declining website visits can precede revenue slowdowns. AltIndex tracks web traffic as one of 25+ signals in its AI Score model.
No single data point predicts a stock price on its own, but website traffic is a leading indicator: a sustained shift in Oramed Pharmaceuticals's monthly visitors can show up before it reaches reported revenue. That is why AltIndex combines ORMP's web traffic trend with hiring, sentiment, app downloads, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Oramed Pharmaceuticals underperforms its industry peers when it comes to Webpage traffic, ranking dead last.
Sign up and get more insights on Oramed Pharmaceuticals and its Webpage performance.
See Oramed Pharmaceuticals’s complete webpage traffic history
Sign up to unlock 1-year and all-time charts for ORMP, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
